Nicotine-Ceria Nanoparticle Complex for Neuroprotection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neurodegenerative diseases such as Parkinson's disease face challenges due to low bioavailability and stability issues of nicotine, which limits its therapeutic effectiveness, and existing antioxidants fail to adequately address oxidative and nitrosative stress contributing to these conditions.
Innovation Solution
A complex of nicotine and cerium oxide nanoparticles coated with a biodegradable agglutinin, such as wheat germ agglutinin, is developed to provide sustained release and enhanced bioavailability, leveraging ceria's radical scavenging properties and the agglutinin's ability to impart colloidal stability and targeted delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nicotine is administered to treat neurodegenerative diseases, then neuroprotective effects are achieved, but bioavailability is low
Solution Approach 1:
The patent combines nicotine with cerium oxide nanoparticles to create a composite material that leverages both components' benefits. The cerium oxide core provides antioxidant properties and radical scavenging capability, while also serving as a carrier to enhance nicotine delivery and bioavailability to neural tissues.
Solution Approach 2:
The biodegradable coating acts as an intermediary substance that facilitates nicotine delivery. This coating layer protects nicotine during administration, controls its release rate, and enhances its solubility and bioavailability without altering the fundamental neuroprotective mechanism of nicotine.
2Object-affected harmful factors
If antioxidants are administered to treat oxidative stress, then radical scavenging is achieved, but stability after administration is poor
Solution Approach 1:
The cerium oxide nanoparticle core provides exceptional stability while maintaining antioxidant activity. The composite structure protects the antioxidant components from degradation in the biological environment, ensuring sustained radical scavenging capability throughout the body.
Solution Approach 2:
The biodegradable coating serves as a protective cushion that shields the antioxidant components from premature degradation. This coating is designed to degrade controllably after delivering its protective function, providing beforehand protection against instability issues.
3Object-affected harmful factors
If nicotine patches are used for treatment, then safety is improved, but delivery speed to brain is slow
Solution Approach 1:
The biodegradable coating is engineered with dynamic degradation properties that allow controlled release of nicotine. The coating degrades at a rate that optimizes delivery speed, providing faster brain delivery than traditional patches while maintaining the safety advantages of non-smoking administration methods.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nicotine-cerium oxide complex effectively modulates autophagy and antioxidant defenses, potentially slowing disease progression and improving motor functions in animal models of Parkinson's disease, while providing a safer and more effective therapeutic intervention for neurodegenerative disorders.
Implementation Method 1
Ceria nanoparticles have a unique ability to switch oxidation states between III and IV. This ability to switch between oxidation states is comparable to that of biological antioxidants, thereby inparting to the ceria nanoparticles the very important biological property of radical scavenging.
Implementation Method 2
The biodegradable coating provides a sustained release of the particles and/or nicotine to neurons
Implementation Method 3
The biodegradable coating provides a sustained release of the particles and/or nicotine to neurons, in addition to imparting colloidal stability to the particles.
Data Source
AI summary
Disclosed are particles comprising a complex of nicotine and cerium oxide and a biodegradable coating comprising agglutinin. Also disclosed is a method of treating or preventing neurodegenerative or neurological disorders in a mammal in need thereof, comprising administering to the mammal a therapeutically effective amount of the particles.